Axonics AXNX Stock
Axonics Price Chart
Axonics AXNX Financial and Trading Overview
| Axonics stock price | 67.6 USD |
| Previous Close | 50.88 USD |
| Open | 50.88 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 900 |
| Day's Range | 50.5 - 52.61 USD |
| 52 Week Range | 47.59 - 79.92 USD |
| Volume | 620.44K USD |
| Avg. Volume | 600.76K USD |
| Market Cap | 2.64B USD |
| Beta (5Y Monthly) | 0.395278 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 77.75 USD |
AXNX Valuation Measures
| Enterprise Value | 2.29B USD |
| Trailing P/E | N/A |
| Forward P/E | -1309.5 |
| PEG Ratio (5 yr expected) | -1.97 |
| Price/Sales (ttm) | 8.917922 |
| Price/Book (mrq) | 4.552012 |
| Enterprise Value/Revenue | 7.741 |
| Enterprise Value/EBITDA | -116.597 |
Trading Information
Axonics Stock Price History
| Beta (5Y Monthly) | 0.395278 |
| 52-Week Change | 8.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 79.92 USD |
| 52 Week Low | 47.59 USD |
| 50-Day Moving Average | 53.68 USD |
| 200-Day Moving Average | 61.31 USD |
AXNX Share Statistics
| Avg. Volume (3 month) | 600.76K USD |
| Avg. Daily Volume (10-Days) | 510.51K USD |
| Shares Outstanding | 50.38M |
| Float | 49.93M |
| Short Ratio | 5.64 |
| % Held by Insiders | 0.81% |
| % Held by Institutions | 103.26% |
| Shares Short | 4.07M |
| Short % of Float | 9.06% |
| Short % of Shares Outstanding | 8.06% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -15.63% |
| Operating Margin (ttm) | -10.52% |
| Gross Margin | 73.30% |
| EBITDA Margin | -6.63% |
Management Effectiveness
| Return on Assets (ttm) | -3.26% |
| Return on Equity (ttm) | -8.89% |
Income Statement
| Revenue (ttm) | 295.93M USD |
| Revenue Per Share (ttm) | 6.22 USD |
| Quarterly Revenue Growth (yoy) | 45.89% |
| Gross Profit (ttm) | 197.67M USD |
| EBITDA | -19647000 USD |
| Net Income Avi to Common (ttm) | -46278000 USD |
| Diluted EPS (ttm) | -1.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 357.06M USD |
| Total Cash Per Share (mrq) | 7.09 USD |
| Total Debt (mrq) | 8.74M USD |
| Total Debt/Equity (mrq) | 1.52 USD |
| Current Ratio (mrq) | 7.098 |
| Book Value Per Share (mrq) | 11.507 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.58M USD |
| Levered Free Cash Flow (ttm) | 46.68M USD |
Profile of Axonics
| Country | United States |
| State | CA |
| City | Irvine |
| Address | 26 Technology Drive |
| ZIP | 92618 |
| Phone | 949 396 6322 |
| Website | https://www.axonics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 610 |
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Q&A For Axonics Stock
What is a current AXNX stock price?
Axonics AXNX stock price today per share is 67.6 USD.
How to purchase Axonics stock?
You can buy AXNX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Axonics?
The stock symbol or ticker of Axonics is AXNX.
Which industry does the Axonics company belong to?
The Axonics industry is Medical Devices.
How many shares does Axonics have in circulation?
The max supply of Axonics shares is 51M.
What is Axonics Price to Earnings Ratio (PE Ratio)?
Axonics PE Ratio is now.
What was Axonics earnings per share over the trailing 12 months (TTM)?
Axonics EPS is -0.12 USD over the trailing 12 months.
Which sector does the Axonics company belong to?
The Axonics sector is Healthcare.
Axonics AXNX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2541.54 USD — |
-1.89
|
— — | 2531.95 USD — | 2572.66 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}